Cash · 2011–2025
Heron Therapeutics cash
$28.6M+11.0% · FY2025
Heron Therapeutics (HRTX) reported $28.6M in cash for fiscal 2025, +11.0% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $28.6M | +11.0% | Open → |
| FY20242024-12-31 | $25.8M | −10.0% | Open → |
| FY20232023-12-31 | $28.7M | +86.7% | Open → |
| FY20222022-12-31 | $15.4M | −83.0% | Open → |
| FY20212021-12-31 | $90.5M | −13.9% | Open → |
| FY20202020-12-31 | $105M | +46.2% | Open → |
| FY20192019-12-31 | $71.9M | +125.8% | Open → |
| FY20182018-12-31 | $31.8M | −78.0% | Open → |
| FY20172017-12-31 | $145M | +977.9% | Open → |
| FY20162016-12-31 | $13.4M | −82.2% | Open → |
| FY20152015-12-31 | $75.2M | +3.4% | Open → |
| FY20142014-12-31 | $72.7M | +0.5% | Open → |
| FY20132013-12-31 | $72.3M | +35.1% | Open → |
| FY20122012-12-31 | $53.5M | +197.7% | Open → |
| FY20112011-12-31 | $18.0M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +3.4%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Heron Therapeutics cash |url=https://companiesranked.com/en/company/heron-therapeutics/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Heron Therapeutics cash. CompaniesRanked. https://companiesranked.com/en/company/heron-therapeutics/cash-on-handBibTeX
@misc{companiesranked-en-company-heron-therapeutics-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Heron Therapeutics cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/heron-therapeutics/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-341301 · August 10, 2026
{{cite web |title=Heron Therapeutics cash — 10-Q (0001193125-26-341301) |url=https://www.sec.gov/Archives/edgar/data/818033/000119312526341301/hrtx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-10}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.